Ignite Creation Date:
2025-12-25 @ 2:45 AM
Ignite Modification Date:
2025-12-26 @ 1:24 AM
Study NCT ID:
NCT04693533
Status:
RECRUITING
Last Update Posted:
2025-01-22
First Post:
2020-12-29
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Fremanezumab, Migraine and Sleep
Sponsor:
Beth Israel Deaconess Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-07-29
Start Date Type:
ACTUAL
Primary Completion Date:
2025-07-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-07-30
Completion Date Type:
ESTIMATED
First Submit Date:
2020-12-29
First Submit QC Date:
None
Study First Post Date:
2021-01-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-21
Last Update Post Date:
2025-01-22
Last Update Post Date Type:
ACTUAL